Nicotinamide Mononucleotide NMN Market Insights Video
According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMNmarket size is USD 115.9 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 46.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 34.77 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 26.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
Latin America had a market share for more than 5% of the global revenue with a market size of USD 5.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
Middle East and Africa hada market share of around 2% of the global revenue and was estimated at a market size of USD 2.32 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
The Online retail is currently the dominant distribution channel in the Nicotinamide Mononucleotide (NMN) market. The convenience and widespread availability of NMN supplements through e-commerce platforms have significantly contributed to the dominance of online retail.
